Inventor
WILSON TROY EDWARD
US35 patents
⚠️ This page may combine multiple inventors who share the name “WILSON TROY EDWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTELLIKINE LLC
16 patentsUS9359349B2Jun 7, 2016
Substituted quinazolines as kinase inhibitors
INTELLIKINE LLC56 citations98
US9315505B2Apr 19, 2016
Heterocyclic compounds and uses thereof
INTELLIKINE LLC64 citations98
US9522146B2Dec 20, 2016
Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof
INTELLIKINE LLC10 citations92
US9216982B2Dec 22, 2015
Certain chemical entities, compositions and methods
INTELLIKINE LLC8 citations92
US9828378B2Nov 28, 2017
Kinase inhibitors and methods of use
INTELLIKINE LLC6 citations84
US9296742B2Mar 29, 2016
Heterocyclic kinase inhibitors
INTELLIKINE LLC6 citations84
US9206182B2Dec 8, 2015
Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof
INTELLIKINE LLC8 citations84
US9669032B2Jun 6, 2017
Enhanced treatment regimens using mTOR inhibitors
INTELLIKINE LLC13 citations82
US9174994B2Nov 3, 2015
Enhanced treatment regimens using mTor inhibitors
INTELLIKINE LLC9 citations82
US9637492B2May 2, 2017
Benzothiazole kinase inhibitors and methods of use
INTELLIKINE LLC2 citations73
US9655892B2May 23, 2017
Certain chemical entities, compositions and methods
INTELLIKINE LLC1 citations63
US9345706B2May 24, 2016
Benzoxazole kinase inhibitors and methods of use
INTELLIKINE LLC1 citations63
US11433065B2Sep 6, 2022
Certain chemical entities, compositions and methods
INTELLIKINE LLC0 citations62
US9822131B2Nov 21, 2017
Certain chemical entities, compositions and methods
INTELLIKINE LLC0 citations52
US9790228B2Oct 17, 2017
Heterocyclic kinase inhibitors
INTELLIKINE LLC1 citations52
US9359352B2Jun 7, 2016
Substituted benzimidazoles as PI3 kinase inhibitors
INTELLIKINE LLC0 citations52
REN PINGDA
15 patentsUS8193182B2Jun 5, 2012
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
REN PINGDA93 citations99
US9096611B2Aug 4, 2015
Kinase inhibitors and methods of use
REN PINGDA65 citations98
US8569323B2Oct 29, 2013
Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof
REN PINGDA61 citations98
US9127000B2Sep 8, 2015
Heterocyclic compounds and uses thereof
REN PINGDA30 citations94
US9085560B2Jul 21, 2015
Heterocyclic compounds and uses thereof
REN PINGDA37 citations94
US8901133B2Dec 2, 2014
Heterocyclic compounds and uses thereof
REN PINGDA44 citations94
US8703777B2Apr 22, 2014
Certain chemical entities, compositions and methods
REN PINGDA36 citations94
US8785454B2Jul 22, 2014
Heterocyclic compounds and uses thereof
REN PINGDA24 citations93
US8703778B2Apr 22, 2014
Heterocyclic kinase inhibitors
REN PINGDA20 citations93
US8785456B2Jul 22, 2014
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
REN PINGDA25 citations92
US8993580B2Mar 31, 2015
Benzothiazole kinase inhibitors and methods of use
REN PINGDA11 citations84
US9096590B2Aug 4, 2015
Substituted benzoxazoles as PI3 kinase inhibitors
REN PINGDA5 citations73
US9295673B2Mar 29, 2016
Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
REN PINGDA4 citations72
US8476431B2Jul 2, 2013
Benzoxazole kinase inhibitors and methods of use
REN PINGDA3 citations63
US8476282B2Jul 2, 2013
Benzoxazole kinase inhibitors and methods of use
REN PINGDA3 citations63